TD Cowen Reiterates Buy Rating on Standard BioTools Inc (LAB)
Tweet Send to a Friend
TD Cowen analyst Daniel Brennan reiterated a Buy rating and $2.75 price target on Standard BioTools Inc (NASDAQ: LAB).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
